Sialyl-Tn is a carbohydrate antigen over-expressed in several epithelial cancers, including breast cancer, and usually associated with poor prognosis. Sialyl-Tn is synthesized by a CMPNeu5Ac:GalNAca2,6-sialyltransferase: ST6GalNAc I, which transfers a sialic acid residue in 
Introduction
Over-expression of sialylated antigens at the surface of cancer cells has been widely reported (Dabelsteen 1996, Kim and Varki 1997) . Among these antigens, STn (Neu5Aca2-6GalNAca1-O-Ser/Thr) is an O-linked disaccharide structure abnormally expressed in several epithelial cancers (i.e. gastric, pancreatic, colorectal, ovarian and breast cancers) (Julien and Delannoy 2003) . STn antigen is often associated with lymph node involvement, distant metastasis and a decreased survival of patients in gastric (Imada et al., 1999 , Takano et al., 2000 , Nakagoe et al., 2002 , colorectal (Nakagoe et al., 2001 ) and breast cancers (Schmitt et al., 1995 , Soares et al., 1996 . Although STn expression is usually associated with poor prognosis, nothing is known about the effective incidence of the antigen expression on the biological properties of cancer cells.
The biosynthesis of O-glycans is a post-translational process that occurs in the Golgi apparatus requiring the sequential action of several membrane-bound glycosyltransferases.
The first step is the transfer of an N-acetylgalactosamine (GalNAc) residue onto a serine or a threonine residue of the protein backbone. Subsequent addition of galactose (Gal) and/or Nacetylglucosamine (GlcNAc) by specific glycosyltransferases leads to the formation of the common O-glycan core structures. These cores can be further elongated and terminated by the transfer of sialic acid or fucose. Alternatively, a premature sialylation of GalNAc or Core 1 may prevent the elongation of the glycans (Figure 1 ). Since many of the oligosaccharide structures that occur in this biosynthetic pathway may serve as acceptor substrates for a variety of glycosyltransferases, the relative activities and the competitive specificities of these enzymes is thought to rule the sequence of the newly synthesized glycans. For example, relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine the prevalence of Core 1 structure in breast cancer cell lines (Figure 1 ) (Dalziel et al., 2001 ).
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The sialyltransferase ST6GalNAc I is able to sialylate the Tn antigen (GalNAca1-O-Ser/Thr) carried by asialo-ovine submaxillary mucin (Ikehara et al., 1999) . Moreover, STn antigen expression is correlated with ST6GalNAc I activity in malignant colonic cells (Ikehara et al., 1999 and it is well accepted that ST6GalNAc I is the STn synthase.
However, well-established breast cancer cell lines used in cancer research do not express this enzyme (Julien et al., 2001) . We have previously reported the generation of MDA-MB-231 and T47-D clones, which stably express ST6GalNAc I after transfection of the cDNA of ST6GalNAc I, and consequently the STn antigen (Julien et al., 2001 , Julien et al., 2005 .
In this paper, we present the precise O-glycosylation pattern of MUC1-MFP6, a secreted recombinant protein containing six tandem repeats of MUC1 and expressed by STn positive (STn + ) cells. We also determine the influence of O-glycosylation modifications on tumour cell growth both in vitro and in vivo. analysed by Western blot using the anti-STn HB-STn1 mAb. As shown in Figure 2A , there was no immunostaining in mock transfected control cells whereas several stained bands ranging from 90 to >200 kDa were detected in both MDA-MB-231 STn + clones. MUC1 and CD44 were immunoprecipitated from total cell lysates using LICR-LON-M8 and HCAM-DF1485 mAbs respectively. Immunoprecipitates were then subjected to SDS-PAGE and Western blot using the HB-STn1 mAb. As shown in Fig. 2B A clone, as previously described (Muller and Hanisch 2002) . The MUC1-MFP6 fusion protein was purified from conditioned medium and the O-glycan pool was released by hydrazinolysis and analyzed by normal phase HPLC (Muller and Hanisch 2002) . As indicated in Table I , the expression of ST6GalNAc I converted 22 % of total Oglycans to STn antigen, while this antigen was not expressed in ST6GalNAc I negative cells.
Results

STn antigen is detected on various O-glycosylproteins in STn
In parallel, Core 1 and Core 2 related structures were decreased by 23 %, confirming that STn antigen is expressed instead of pre-existing more extended structures. This result also clearly indicates that overexpressed ST6GalNAc I competes with the Core1bGalT, which is the key enzyme in the biosynthesis of Core 1 and Core 2 related structures (Figure 1 ). Furthermore, we observed an increase of sialyl-6T (from 5.4 % to 15.7 %) and a concomitant decrease of sialyl-3T (from 27.6 % to 17.2 %) in STn (Table I) .
Structural characterisation of O-linked glycans by mass spectrometric sequencing and linkage analysis
The monosaccharide composition of permethylated glycan alditols was deduced from the sodiated molecular ions in terms of N-acetylneuraminic acid (NeuAc), deoxyhexose (dHex), hexose (Hex), and N-acetyhexosamine (HexNAc) ( Table II) . The compositional data were in agreement with the major species profiled by HPLC analysis (see above and table I).
Sequence information was obtained by collision-induced dissociation experiments in ESI-MS and registration of MS/MS spectra, which revealed prominent fragment ions of the Y, Z and B, C series (Domon and Costello 1988) for sodiated molecular ions (Table II) . The ion at m/z 895 was a mixture of two isomeric trisaccharide alditols indicated by the respective Y 2 and Z 1 ions (NeuAc-Hex-HexNAc-ol) and by the Y 1a and Z 1a ions (NeuAc-(Hex-)HexNAc-ol).
Another structural isomery was revealed for the M+Na ion at m/z 1344, which corresponded to two isomeric pentasaccharide alditols. Sequence assignments were corroborated by complementary MS/MS spectra registered for the corresponding protonated molecular ions, which yield preferentially B ion series (not shown).
Linkage analysis by GC-MS identification of partially methylated alditol acetates via specific fragment ions (Table III) revealed the presence of terminal galactose (2,3,4,6-tetra-O-methyl-
3,6-linked GalNAc-ol (major 4-mono-O-methyl-1,3,5,6-tetra-O-acetyl-Nacetylgalactosaminitol) and 4, . According to these data, the major ion at m/z 691 (Table II) , corresponding to the disaccharide alditol NeuAc-HexNAc-ol, is identified as NeuAc2-6GalNAc-ol and confirms the de novo formation of STn in cotransfected MDA-MB-231 cells.
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No terminal fucose or 2-linked Gal was registered indicating absence of blood-group H structures. The same holds true for branched polylactosamines (absence of 3,6-linked Gal), type 1 lactosamines (absence of 3-linked GlcNAc) and Lewis-type glycans (absence of 3,4-linked GlcNAc).
Influence of STn expression on cell growth and cell mobility.
In standard monolayer culture conditions, there was no significant difference in growth curves of the STn + clones compared to STn -cells after 6 days of culture ( Figure 3A) .
In contrast, analysis of cell motility using Transwell system showed a 1.6-fold increase of migrating cells for STn 
STn expression and BGN treatment both decrease cell adhesion.
As shown in Figure 4C , STn been demonstrated that BGN is converted into the disaccharide Galb1-3GalNAca-O-bn by the Core-1 b1,3-galactosyltransferase, but this conversion does not impair the b1,3-galactosylation of GalNAc O-linked to the proteins expressed by the cells. However, the soluble disaccharide Galb1-3GalNAca-O-bn has been proven to behave as a strong competitive inhibitor of the elongation of the mucin Galb1-3GalNAca sequences by N-acetylglucosaminyltransferases, sialyltransferases and fucosyltransferases , Zanetta et al., 2000 . Thus, when it is incorporated by cells, BGN mainly acts as an inhibitor of the elongation or either the sialylation of the Galb1-3GalNAca sequence (T antigen) of mucins (Figure 1 ). The efficiency of BGN treatment on our models was verified by subjecting both treated and untreated STn -and STn + cells to PNA labeling, using either flow cytometry ( Figure 4A ) or Western blot ( Figure 4B ).
As shown in Figure 4A 
Discussion
Over expression of STn antigen occurs in almost 40 % of the breast cancers (Julien and Delannoy 2003) and is correlated with a decreased overall survival of the patients (Miles et al., 1994 , Kinney et al., 1997 , Imai et al., 2001 , Leivonen et al., 2001 . Although STn antigen expression seems to be related to cancer development, very little is known about its direct involvement in cellular mechanisms that may increase the aggressiveness of the tumour. In order to clarify the actual incidence of STn expression on biological properties of breast cancer cells, we have undertaken the characterisation of MDA-MB-231 clones stably expressing ST6GalNAc I, the STn synthase (Julien et al., 2001) , with regard to their Oglycosylation pattern and biological behaviour both in culture and in vivo.
STn is an O-linked antigen carried by mucins or by glycoproteins containing mucin-like domains. In particular, STn has previously been reported to be associated with MUC1 in pancreatic, colonic and breast cancer cells (Burdick et al., 1997 , Julien et al., 2005 , with CD44 in colonic cancer cells (Singh et al., 2001) , and with the integrin bI subunit in mouse mammary cancer cells (Clement et al., 2004 ). Here we show that both MUC1 and CD44 bear the STn antigen in MDA-MB-231 ST6GalNAc I transfectants, designated these proteins as common STn carriers. In contrast, we never succeeded in revealing the STn antigen on immuno-precipitated integrin bI subunit from human breast cancer cell lines (data not shown).
Furthermore, the pattern of STn carrying glycoproteins that we describe in this paper is different from the pattern we previously described in STn + T47-D (Julien et al., 2005) . Some of these proteins seem to be commonly expressed in both cell lines (i.e. MUC1), whereas others are cell line specific (i.e. CD44), however most of them remain unidentified. It seems that multiple combinations of Stn-carrying glycoproteins might be variously expressed by the cells depending on pecies, cell type or even the cell line.
We have investigated the effect of ST6GalNAc I expression on the O-glycosylation pattern in (Table I ). This lowering of Core 1 expression is confirmed by the decreased PNA reactivity of the transfected cells (Figure 4 ). Mass spectrometry analysis also reveals that ST6GalNAc I expression modifies the sialylation pattern of the remaining Core 1, decreasing a3-sialylation and increasing a6-sialylation. Indeed, ST6GalNAc I is also able to sialylate the Galb1-3GalNAca1-O-Ser/Thr structure (Ikehara et al., 1999) , leading to sialyl-6T expression. This reveals that there is an enzymatic competition between ST6GalNAc I and ST3Gal I for the use of the Core 1 structure as acceptor substrate (Figure 1 ). However, since ST6GalNAc I is not active on BGN-derivatives (Ikehara et al., 1999 , Marcos et al., 2004 , O-glycoproteins functions. Indeed, it has been described that over sialylation enhances the anti-adhesive properties of MUC 1 in both normal and tumour cells (Ligtenberg et al., 1992 , Wesseling et al., 1996 . In addition, it has been reported that shortening of the O-glycans carried by CD44 increases the CD44-mediated adhesion of colonic cancer cells to hyaluronic acid (Dasgupta et al., 1996) , potentially regulating their adhesion and migration (Naor et al., 1997, Herrera-Gayol and Jothy 1999) . Since both MUC1 and CD44, expressed at the cell surface, exhibit a modified O-glycosylation pattern in MDA-MB-231 transfectants, these proteins might be involved in the phenotype changes we report. However, STn antigen appears to be carried by several other glycoproteins, some of them either more highly expressed or more densely glycosylated than MUC1 or CD44 (Figure 2 ). These unknown STn bearing glycoproteins remain to be identified in order to determine whether or not they may be involved in the molecular mechanisms responsible of adhesion and migration changes. cancers (Davidson et al., 2000) . Finally, we show that STn expression enhances tumourigenicity in SCID mice, suggesting that the deregulation of O-glycans biosynthesis has a direct impact on tumour development. We propose therefore, that MDA-MB-231 STn + clones constitute a strong cellular tool to further investigate the molecular mechanisms that enhance the STn positive breast cancer aggressiveness. 
Materials and methods
Cell
Electrophoresis and Western blotting:
Cells from confluent 100 mm diameter dishes were lysed with PBS containing 1% Triton X-100, 1% NP-40, 300 µg.ml -1 PMSF, 10 µg.ml -1 leupeptin and 10 µg.ml -1 aprotinin. One hundred µg of protein were loaded on a 4 -16% gradient SDS-PAGE under reducing conditions. Electroblotting on nitrocellulose membranes (Biotrace NT; Gelman Science, Ann Arbor, MI) was in accordance with standard procedures (Vaessen et al., 1981) . For STn blotting, the membrane was treated with fat free milk (5% in TBS) and incubated with the HB-STn1 mAb (Dako), diluted 1/500 in TBS Tween 0.05%, for 90 min. The membrane was then incubated for 90 min. with anti-mouse IgG1 alkaline phosphatase-labeled Fab fragments (Santa-Cruz) (1/2500 in TBS Tween 0.05%, for 90 min). Isolation and purification of MUC1 constructs from culture supernatants: as previously described, supernatants from confluent cell cultures were collected and proteins were separated by immobilized metal chelate affinity chromatography (Muller and Hanisch 2002) .
Anti-myc positive fractions were subjected to further purification by HPLC on a reversedphase C 8 -column (Vydac 214TP3410, MZ Analysentechnik, Mainz, Germany) (Muller and Hanisch 2002) .
Liberation, fluorescence labeling and analysis of O-linked glycans:
glycans were liberated by hydrazinolysis, labeled with 1 M 2-aminobenzamide in acetic acid and 2 M sodium cyanoborohydride in dimethyl sulfoxide for 2 hours at 60°C (Bigge et al., 1995) and purified by ascending paper chromatography using 1-butanol, ethanol and water (4:1:1, v/v/v) as solvent. Labeled O-glycan pools were analyzed using normal-phase HPLC and identification was based on external standard oligosaccharides, differential chromatography prior to and after sialidase treatment and on mass spectrometric analysis (Muller and Hanisch 2002) .
Mass spectrometric sequencing of permethylated glycan alditols -
Electrospray ionization (ESI) mass spectrometry data were acquired on a Q-Tof 2 quadrupoletime of flight mass spectrometer (Waters, Eschborn, Germany) equipped with a Z spray source. ESI(Qtof) mass spectrometry was performed in the positive ion mode using previously described conditions (Morelle et al., 2004) . The permethylated glycans were dissolved in 80% methanol containing 1% acetic acid before loading 3 µl into a nanospray capillary coated with a thin layer of gold/palladium, tip inner diameter 2 µm (Proxeon, Odense, Denmark). A potential of 800 V was applied to a nanoflow tip. The drying gas used was nitrogen and the collision gas was argon, with the collision gas pressure maintained at 0.5 bar. The cone voltage was set at 50 V. Collision energies varied in accordance with the type of molecular ion (M+Na: 50 -75 V; M+H: 15 -30 V).
Chemical derivatisation for GC-MS and ESI-MS/MS -
Permethylation was performed using the sodium hydroxide procedure of Ciacanu and Kerek as modified by Anumula (Anumula and Taylor 1992) . Partially methylated alditol acetates were prepared by hydrolysis of permethylated glycans with 2M TFA (Fluka) for 2h at 121°C, by reduction with 10 mg/ml sodium borodeuteride (Sigma) in 2M aqueous ammonium hydroxide at room temperature for 2h and acetylation with acetic anhydride (Fluka) at 100°C for 1h (Albersheim et al., 1967) . The partially methylated alditol acetates were extracted with chloroform-water, dried and analysed as a dichloromethane solution by GC-MS on a Fison MD800 (Thermo Electron, Dreieich, Germany) using a 15m RTX5-SILMS column from Restek (Bad Homburg, Germany) and a temperature gradient from 60 to 100°C (40°C/min) followed by 100 to 280°C (10°C/min).
Monolayer growth assay: cells (5x10
3 ) were seeded in 96 well black plates (Costar) and cultured in 10% FCS-containing medium. Cell growth was determined every day. Cells were washed once with PBS, fixed with cold methanol (20 min, -20°C) and stained with Hoechst 33528 (Sigma). The fluorescence of stained nuclei was measured using a microplate fluorescence reader (FL X 800 -BIO-TEK Instrument, Inc.).
Cell migration analysis
Transwell system analysis: cells (2.10 4 ) were seeded in Transwell 12 well plates (Costar) and incubated 18 hours in 10 % FCS-containing medium. Cells were fixed and stained with Hoechst 33528 (Sigma). The stained migrating cells, which had crossed the porous membrane, were then counted under fluorescence microscopy. Monosialyl-Core 2 
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